Jonathan McNeill

CIK 1824673 · President and COO · last filed 2025-12-17

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.40M

Companies

2

Total Filings

29

Lifetime Open-Market Net

-$5.63M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CRESCENT BIOPHARMA, INC. (GLYC) Delisted President and COO 153,707 $15.70 $2.41M $0 2 2025-12-17
DYN Chief Business Officer 132,106 $18.19 $2.40M -$5.63M 27 2024-08-20

Recent Filings · Page 2 of 3

29 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-01-04 DYN Mixed −11,900 -$514.6K EDGAR
2023-12-12 DYN Sell (S) −1,245 -$13.3K EDGAR
2023-11-16 DYN Grant (A) +96,158 $0 EDGAR
2023-09-20 DYN Sell (S) −1,261 -$11.9K EDGAR
2023-09-13 DYN Sell (S) −1,266 -$13.2K EDGAR
2023-06-14 DYN Sell (S) −2,259 -$28.6K EDGAR
2023-03-15 DYN Sell (S) −2,209 -$29.1K EDGAR
2023-01-23 DYN Mixed -$133.0K EDGAR
2023-01-11 DYN Sell (S) −30,150 -$348.8K EDGAR
2022-12-13 DYN Mixed +39,528 -$5.1K EDGAR
Showing 1120 of 29
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.